| Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. | |
| Since the 1960s, silicon nanostructures, the building-blocks of microchips, have supercharged the development of electronics, communications, manufacturing, medicine, and more. | |
| How small are these nanostructures? Very, very small – you could fit at least 3,000 silicon transistors onto the tip of a human hair. But there is a limit: below about 5 nanometres (5 millionths of a millimetre), it is hard to improve the performance of silicon devices any further. | |
| So if we are about to exhaust the potential of silicon nanomaterials, what will be our next signature material? That’s where “atomaterials” come in. | |
What are atomaterials? |
|
| “Atomaterials” is short for “atomic materials”, so called because their properties depend on the precise configuration of their atoms. It is a new but rapidly developing field. | |
| One example is graphene, which is made of carbon atoms. Unlike diamond, in which the carbon atoms form a rigid three-dimensional structure, graphene is made of single layer of carbon atoms, bonded together in a two-dimensional honeycomb lattice. | |
| Diamond’s rigid structure is the reason for its celebrated hardness and longevity, making it the perfect material for high-end drill bits and expensive jewellery. In contrast, the two-dimensional form of carbon atoms in graphene allows electron travelling frictionless at a high speed giving ultrahigh conductivity and the outstanding in plane mechanical strength. Thus, graphene has broad applications in medicines, electronics, energy storage, light processing, and water filtration. | |
| Using lasers, we can fashion these atomic structures into miniaturised devices with exceptional performance. |
Image Credit: Swinburne
News This Week
Researchers flag similarities between COVID-19 deaths and severe rheumatic illnesses
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against [...]
Next-gen nano technologies to tackle infection and diagnose disease
Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and [...]
DeepMind’s Protein Folding AI Is Going After Coronavirus
In late December last year, Dr. Li Wenliang began warning officials about a novel coronavirus in Wuhan, China, but was silenced by the police before tragically succumbing to the disease two months later. Meanwhile, [...]
COVID-19 is like three different diseases, says New York doctor
Almost 10 weeks into the pandemic, COVID-19 is continuing to surprise and baffle health experts. In fact, experts' picture of exactly how COVID-19 might play out in the body is now quite different to [...]
Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. This approach opens the possibility to engineer safer and more effective vaccines. Vaccines [...]
Tiny RNA that should attack coronavirus diminish with age and disease
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why [...]
COVID-19 Coronavirus blood-clot mystery intensifies
Purple rashes, swollen legs, clogged catheters and sudden death — blood clots, large and small, are a frequent complication of COVID-19, and researchers are just beginning to untangle why. For weeks, reports have poured [...]
Coronavirus vaccine trials are underway around the world. China’s hoping it can be first for ‘redemption’
In a medical centre in the eastern city of Xuzhou, a few dozen healthy adults have become some of the first to trial a vaccine candidate for the coronavirus. They are among a small [...]
Epitopes.world taps AI to predict COVID-19 vaccine success
A team of researchers hailing from Harvard and Université de Montréal today launched Epitopes.world, an AI-powered, interactive platform designed to facilitate COVID-19 vaccine development. It’s built atop an algorithm — CAMAP — that generates predictions for potential [...]
Publication of our paper “Human Brain/Cloud Interface” in Frontiers Neuroscience Ebook
The "Human Brain/Cloud Interface" paper had more views that 99% of Frontiers articles. It has now been added to Frontier's "Nanotechnologies in Neuroscience and Neuroengineering" ebook which is available for download. Contributors: Frank J. [...]
The scientific advances we need to stop COVID-19 by Bill Gates
This is the full-length version of this post. You can read the condensed version, which appeared as an opinion article in the Washington Post, here. The coronavirus pandemic pits all of humanity against the virus. The [...]
New nanophotonic saliva/nasal swab test to instantly detect coronavirus with lasers
European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes. Responding to the European Commission’s Express Calls to [...]
Why COVID-19 may attack the body differently than we think
Understanding how COVID-19 attacks the human body is essential to developing an effective treatment or vaccine to stop the global pandemic — but there's still so much we don't know about how it can kill us. As [...]
Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment
Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a [...]
Coronavirus mutation could threaten the race to develop vaccine
A coronavirus strain isolated in India carried a mutation that could upend vaccine development around the globe, according to researchers from Australia and Taiwan. The non-peer reviewed study said the change had occurred in [...]
COVID-19: Anti-parasitic drug Ivermectin eliminates SARS-CoV-2 in cells in 48 hours
Ivermectin shows promise as potential COVID-19 therapy. Summary: An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. [...]
